Project Grant R01MH138380

Award Date 12/1/24
Completion Date 11/30/29
Dollars Obligated $674K
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
Pittsburgh, PA 15222, USA
Similar Awards
The National Institute of Mental Health (NIMH) awarded a $857,216 Project Grant (CFDA 93.242 - Mental Health Research Grants) to The Children's Hospital Corporation, doing business as Boston Children's Hospital, for a 5-year longitudinal study examining neurodevelopmental trajectories and social determinants of health associated with early Attention Deficit Hyperactivity Disorder (ADHD) and disruptive behaviors. The study will leverage an existing NINDS-funded cohort of low-resourced,...
This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $826,902 to the Hugo W. Moser Research Institute at Kennedy Krieger, Inc. to investigate the dynamic relationships between physical activity, sleep, and circadian rhythms with the clinical symptoms and neurobehavioral heterogeneity in children with Attention-Deficit/Hyperactivity Disorder (ADHD). The 5-year study will leverage wearable...
This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $794,931 to the University of California, Davis to conduct research on the relationship between early parent-infant synchrony and middle childhood outcomes among infants at genetic risk for ADHD or autism spectrum disorder (ASD). The research project will leverage three prospective longitudinal cohorts of 326 infants, some of whom have a...
This federal Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $809,312 to Duke University to characterize circadian function and its implications for clinical and cognitive functioning in 250 children with Attention-Deficit/Hyperactivity Disorder (ADHD). The study aims to: 1) use gold-standard dim light melatonin onset (DLMO) assessment and wearable sensors to evaluate sleep/circadian profiles in...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $367,708 to the University of Southern California to investigate the neural mechanisms underlying Autism Spectrum Disorder (ASD) and Attention-Deficit/Hyperactivity Disorder (ADHD). The key objectives of this 5-year research project are to: 1) Examine functional connectivity patterns of reward regions in ASD and ADHD using machine learning and...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), aims to advance the understanding of the genomic mechanisms underlying attention-deficit/hyperactivity disorder (ADHD) in families. The $2,535,618 award will support the development of the largest family-based repository of children diagnosed with primary ADHD (without comorbid autism or intellectual disability) and their family members. The research will...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $742,353 to The Children's Hospital of Philadelphia (CHOP) to develop and pilot test caregiver-facing implementation strategies to support caregivers of children with or at-risk for ADHD in implementing evidence-based behavioral interventions and home-school communication approaches. The project, titled "IMPLEMENTATION STRATEGIES FOR CAREGIVER...
This $174,788 National Science Foundation (NSF) award under the Computer and Information Science and Engineering (CISE) program focuses on enhancing the assessment and diagnosis of Attention Deficit Hyperactivity Disorder (ADHD). The project aims to develop computational approaches to collect and analyze ADHD-related data, leveraging technologies such as inertial movement units, touch-sensitive screens, and high-precision cameras to gather insights into hyperactivity behaviors. The goal is to...
This Project Grant award in the amount of $181,234 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) will fund research to study the impact of early psychostimulant exposure on sleep neurophysiology and circadian rhythms in animal models of Attention-Deficit/Hyperactivity Disorder (ADHD). The research aims to break down the complex relationship between ADHD, psychostimulant medications like methylphenidate, and their...
This federal Project Grant award from the National Institute of Mental Health (NIMH) under CFDA Program 93.242 (Mental Health Research Grants) provides funding to Nurelm Inc. to develop and test the LEMURDX system. LEMURDX is a software platform that uses machine learning and wearable device sensors to objectively measure hyperactivity in children with ADHD. The $615,908 award over 3 years will be used to refine the LEMURDX product to enhance ease of use for clinical researchers, and to test the...

This federal Project Grant award, provided by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), aims to examine the associations between parent-child focused attention, parent-child neural synchrony, and child resting state frontoparietal network connectivity in relation to ADHD symptom trajectories among 210 preschool-aged children.

The $673,803 award, with a performance period from December 1, 2024 to November 30, 2029, will be used to conduct a longitudinal study to identify neural and behavioral predictors of early ADHD symptom trajectories. The study will utilize functional near-infrared spectroscopy (fNIRS) to measure parent-child neural synchrony and its implications for brain development supporting attentional focusing. Researchers aim to uncover potentially malleable parenting behaviors that could support the development of future preventive interventions for ADHD before the onset of full symptoms and associated impairment.

Generated 7/1/25, 4:58 AM